SM
Sabby Management’s Adverum Biotechnologies ADVM Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q4 | – | Hold |
0
| – | – | – | 87 |
|
2018
Q3 | – | Sell |
-27,263
| Closed | -$144K | – | 76 |
|
2018
Q2 | $144K | Sell |
27,263
-171,701
| -86% | -$907K | 0.02% | 63 |
|
2018
Q1 | $1.15M | Sell |
198,964
-101,036
| -34% | -$586K | 0.14% | 23 |
|
2017
Q4 | $1.05M | Buy |
+300,000
| New | +$1.05M | 0.1% | 21 |
|
2017
Q3 | – | Sell |
-110,000
| Closed | -$275K | – | 82 |
|
2017
Q2 | $275K | Sell |
110,000
-172,630
| -61% | -$432K | 0.02% | 80 |
|
2017
Q1 | $763K | Sell |
282,630
-676
| -0.2% | -$1.83K | 0.04% | 56 |
|
2016
Q4 | $822K | Sell |
283,306
-119,297
| -30% | -$346K | 0.05% | 64 |
|
2016
Q3 | $1.66M | Sell |
402,603
-377,323
| -48% | -$1.55M | 0.06% | 42 |
|
2016
Q2 | $2.47M | Buy |
779,926
+239,294
| +44% | +$756K | 0.13% | 33 |
|
2016
Q1 | $2.8M | Buy |
540,632
+345,500
| +177% | +$1.79M | 0.14% | 29 |
|
2015
Q4 | $1.86M | Sell |
195,132
-379,128
| -66% | -$3.61M | 0.1% | 46 |
|
2015
Q3 | $4.73M | Buy |
574,260
+376,460
| +190% | +$3.1M | 0.2% | 29 |
|
2015
Q2 | $3.21M | Buy |
197,800
+142,857
| +260% | +$2.32M | 0.12% | 36 |
|
2015
Q1 | $2.23M | Sell |
54,943
-87,860
| -62% | -$3.56M | 0.09% | 51 |
|
2014
Q4 | $7.71K | Buy |
142,803
+92,803
| +186% | +$5.01K | 0.24% | 13 |
|
2014
Q3 | $1.71K | Buy |
+50,000
| New | +$1.71K | 0.07% | 44 |
|